Evaluating the Utility of mHealth ECG Heart Monitoring for the Detection and Management of Atrial Fibrillation in Clinical Practice

Garan, Hasan; Rr, Sciacca; Riga, Teresa C.; Warren, Kwanza; Ap, Frulla; Nr, Hauser; Dy, Wang; Whang, William

doi:10.4022/jafib.1546

Cited by 29 publications

(25 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A case study of three patients with CIED with varying reported education and patient engagement demonstrated high device acceptance and technological satisfaction . In addition, Hickey et al demonstrated that the use of Kardia device by patient's with atrial fibrillation reported significantly better‐self reported quality of life possibly secondary to an increased awareness that abnormal rhythms, which previously would have gone undetected can be analyzed and treated.…”

Section: Discussionmentioning

confidence: 99%

Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices

Abudan

Isath

Ryan

et al. 2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Introduction Emerging medical technology has allowed for monitoring of heart rhythm abnormalities using smartphone compatible devices. The safety and utility of such devices have not been established in patients with cardiac implantable electronic devices (CIEDs). We sought to assess the safety and compatibility of the Food and Drug Administration‐approved AliveCor Kardia device in patients with CIEDs. Methods and Results We prospectively recruited patients with CIED for a Kardia recording during their routine device interrogation. A recording was obtained in paced and nonpaced states. Adverse clinical events were noted at the time of recording. Electrograms (EGMs) from the cardiac device were obtained at the time of recording to assess for any electromagnetic interference (EMI) introduced by Kardia. Recordings were analyzed for quality and given a score of 3 (interpretable rhythm, no noise), 2 (interpretable rhythm, significant noise) or 1 (uninterpretable). A total of 251 patients were recruited (59% with a pacemaker and 41% with ICD). There were no adverse clinical events noted at the time of recording and no changes to CIED settings. Review of all EGMs revealed no EMI introduced by Kardia. Recordings were correctly interpreted in 90% of paced recordings (183 had a score of 3, 43 of 2, and 25 of 1) and 94.7% of nonpaced recordings (147 of 3, 15 of 2, and 9 of 1). Conclusion The AliveCor Kardia device has an excellent safety profile when used in conjunction with most CIEDs. The quality of recordings was preserved in this population. The device, therefore, can be considered for heart rhythm monitoring in patients with CIEDs.

show abstract

Section: Discussionmentioning

confidence: 99%

Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices

Abudan

Isath

Ryan

et al. 2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

show abstract

“…The preliminary data have shown that over a 6-month follow-up period, patients who were given smartphone-based ECG monitors had more than double the detection rate of AF/AFL recurrence compared with patients monitored via conventional ECG monitors (61% vs 30%). 37 In addition, patients using smartphone-based ECG monitors had a significant improvement in quality of life over the 6-month follow-up period. 37 Our study has shown that smartphone-based ECG monitoring devices improve health care usage.…”

Section: Implications For Clinical Practicementioning

confidence: 95%

“…37 In addition, patients using smartphone-based ECG monitors had a significant improvement in quality of life over the 6-month follow-up period. 37 Our study has shown that smartphone-based ECG monitoring devices improve health care usage. We think that expanding the use of smartphone-based ECG monitoring devices would lead to more accurate assessment of patients' postablation condition and Abbreviations: AF, atrial fibrillation; CI, confidence interval; ECG, electrocardiography; CEM, continuous event monitor; MCT, mobile cardiac telemetry.…”

Section: Implications For Clinical Practicementioning

confidence: 95%

Smartphone ECG Monitoring System Helps Lower Emergency Room and Clinic Visits in Post–Atrial Fibrillation Ablation Patients

Aljuaid

Marashly

Al-Danaf

et al. 2020

Clin Med Insights Cardiol

View full text Add to dashboard Cite

Aim: To evaluate the effectiveness of using a smartphone-based electrocardiography (ECG) monitoring device (ECG Check) on the frequency of clinic or emergency room visits in patients who underwent ablation of atrial fibrillation (AF). Methods: Two groups of patients were identified and compared: The conventional monitoring group (CM group) included patients who were prescribed conventional event monitoring or Holter monitoring systems. The ECG Check group (EC group) included patients who were prescribed the ECG Check device for continuous monitoring in addition to conventional event monitoring. The primary outcome was the number of patient visits to clinic or emergency room. The feasibility, accuracy, and detection rate of mobile ECG Check were also evaluated. Results: Ninety patients were studied (mean age: 66.2 ± 11 years, 64 males, mean CHA2DS2-VASc score: 2.6 ± 2). In the EC group, forty-five patients sent an average of 52.8 ± 6 ECG records for either routine monitoring or symptoms of potential AF during the follow-up period. The rhythm strips identified sinus rhythm (84.7%), sinus tachycardia (8.4%), AF (4.2%), and atrial flutter (0.9%). Forty-two EC transmissions (1.8%) were uninterpretable. Six patients (13%) in the EC group were seen in the clinic or emergency room over a 100-day study period versus 16 (33%) in the standard care arm ( P value < 0.001). Conclusions: Use of smartphone-based ECG monitoring led to a significant reduction in AF-related visits to clinic or emergency department in the postablation period.

show abstract

“…The majority of research has focused on monitoring systems which aim to detect abnormalities in patients through the integration of mobile technologies in their daily life (30,31). For instance, the pairing of a wireless heart monitor to a smartphone, and data transmission over mobile telecommunications networks would provide physicians a constant stream of reports regarding a patient's status (27,32,33). Additionally, through the use of mobile or web based applications, interaction between physician and patient can be achieved on a consistent basis regardless of distance between both parties (34,35).…”

Section: Rural Healthcare Telemedicine and Mobile Health (Mhealth)mentioning

confidence: 99%

Deep learning for cardiac computer-aided diagnosis: benefits, issues & solutions

Loh¹,

Then²

2017

mHealth

View full text Add to dashboard Cite

Cardiovascular diseases are one of the top causes of deaths worldwide. In developing nations and rural areas, difficulties with diagnosis and treatment are made worse due to the deficiency of healthcare facilities. A viable solution to this issue is telemedicine, which involves delivering health care and sharing medical knowledge at a distance. Additionally, mHealth, the utilization of mobile devices for medical care, has also proven to be a feasible choice. The integration of telemedicine, mHealth and computer-aided diagnosis systems with the fields of machine and deep learning has enabled the creation of effective services that are adaptable to a multitude of scenarios. The objective of this review is to provide an overview of heart disease diagnosis and management, especially within the context of rural healthcare, as well as discuss the benefits, issues and solutions of implementing deep learning algorithms to improve the efficacy of relevant medical applications.

show abstract

Evaluating the Utility of mHealth ECG Heart Monitoring for the Detection and Management of Atrial Fibrillation in Clinical Practice

Abstract: Cardiac mHealth self-monitoring is a feasible and effective mechanism for enhancing AF/AFL detection that improves quality of life.

Cited by 29 publications

References 16 publications

Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices

Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices

Smartphone ECG Monitoring System Helps Lower Emergency Room and Clinic Visits in Post–Atrial Fibrillation Ablation Patients

Deep learning for cardiac computer-aided diagnosis: benefits, issues & solutions

Contact Info

Product

Resources

About